How taVNS Supports Digestive Wellness: Vagus Nerve and Gut Function

As the 3rd annual G-PACT conference approaches on March 21, we are honored that ZenoWell will be participating as a sponsor and device donor in support of the community.

At ZenoWell, we are focused on bringing neuroscience-informed wellness technologies into everyday life. One area receiving growing scientific attention is transcutaneous auricular vagus nerve stimulation (taVNS)—a non-invasive neuromodulation approach that may help support autonomic balance, stress regulation, sleep, recovery, and digestive function.

Because many people in the G-PACT community live with complex digestive and gut-motility-related challenges, we wanted to share a high-level overview of the science behind the vagus nerve, taVNS, and why this technology is increasingly relevant to conversations around digestive wellness.

Important note: ZenoWell’s taVNS product is a wellness product. It is not intended to diagnose, treat, cure, or prevent any disease. The research discussed below reflects emerging scientific interest in vagus nerve stimulation and digestive function, but should not be interpreted as a claim of medical efficacy for any specific condition.

What is the vagus nerve?

The vagus nerve is one of the body’s most important communication pathways between the brain and internal organs. It is a major part of the parasympathetic nervous system, which supports “rest, digest, and restore” functions.

The vagus nerve helps regulate processes related to:

• Digestive activity
• Gastric motility and rhythm
• Heart rate and autonomic balance
• Inflammatory signaling
• Stress recovery
• Sleep-related physiology

It also plays a central role in the brain-gut axis—the bidirectional network linking the brain, gut, immune system, and autonomic nervous system. This is one reason why stress, poor sleep, inflammation, and digestive discomfort are often so closely interconnected.

What is taVNS?

Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive approach to stimulating vagus nerve pathways through specific regions of the outer ear.

Unlike implanted vagus nerve stimulation systems, taVNS does not require surgery. It is typically delivered through gentle electrical stimulation applied at the ear, targeting auricular branches associated with vagal afferent signaling.

Researchers are studying taVNS because it may influence:

• Autonomic nervous system balance
• Brain-gut communication
• Stress and recovery pathways
• Neuroimmune signaling
• Pain and discomfort processing
• Sleep and relaxation states

This makes taVNS an especially interesting technology for wellness contexts where whole-body regulation matters.

Why is taVNS relevant to digestion and gut function?

The short answer is simple: the vagus nerve is deeply involved in digestive regulation.

It participates in communication between the brain and the gastrointestinal tract, and is associated with processes such as:

• Gastric slow waves and stomach rhythm
• Motility and gastrointestinal muscle activity
• Signals related to fullness, nausea, and discomfort
• Stress-related changes in digestion
• Inflammatory processes affecting the gut

Because taVNS engages vagal pathways, researchers have been exploring whether it may help influence physiological markers related to digestive function and gut regulation.

What does the research show?

While research is still evolving, several clinical and mechanistic studies suggest that taVNS may affect gastric rhythms, motility, functional digestive symptoms, and neuroimmune regulation.

1. taVNS may influence gastric rhythm and motility: 

• Reduced gastric frequency and altered stomach signaling

A 2019 study by Teckentrup et al. reported that non-invasive stimulation of vagal afferents reduced gastric frequency, suggesting that vagal stimulation can influence stomach electrical activity.

This is notable because the stomach has its own intrinsic electrical rhythm, and disruptions in this rhythm have been associated with digestive discomfort and dysregulated gastric function.

• Randomized, double-blind evidence in healthy adults

In a randomized, double-blind trial, Steidel et al. (2021) found that taVNS influenced gastric motility in healthy individuals, adding controlled human evidence that auricular vagus stimulation may affect stomach function.

• Normalization of induced gastric dysrhythmias

Du et al. (2022) used body-surface gastric mapping and found that taVNS normalized experimentally induced gastric myoelectrical dysrhythmias in healthy controls.

This study is particularly compelling because it suggests that taVNS may help stabilize disrupted gastric electrical patterns under certain experimental conditions.

• Improvement in stress-impaired gastric slow waves

In another study, Zhu et al. (2022) found that noninvasive taVNS improved gastric slow waves impaired by cold stress in healthy participants.

This is especially interesting in the context of the brain-gut axis, because stress and autonomic imbalance are known to affect digestive physiology.

2. taVNS may support functional digestive symptoms

• Functional dyspepsia study

Zhu et al. (2021) reported that taVNS improved functional dyspepsia and suggested that this effect may occur by enhancing vagal efferent activity.

Functional dyspepsia is a complex condition involving upper GI symptoms such as early fullness, discomfort, bloating, and post-meal distress. This study adds to the growing body of evidence linking vagal regulation with digestive symptom support.

3. taVNS may affect gastrointestinal muscle activity more broadly

A prospective clinical trial by Hong et al. (2019) examined the effects of transcutaneous vagus nerve stimulation on muscle activity in the gastrointestinal tract.

Taken together with other motility-focused work, this study supports the broader idea that vagal neuromodulation may influence digestive tract function beyond the stomach alone.

4. taVNS may strengthen stomach-brain communication

A study by Müller et al. found that vagus nerve stimulation increased stomach-brain coupling via a vagal afferent pathway.

This is an important finding because digestive wellness is not only about the gut itself—it is also about how the brain and gut communicate. Brain-gut coupling is increasingly recognized as central to stress-sensitive digestive symptoms and overall interoceptive regulation.

5. Higher-level evidence: constipation and meta-analytic support

A systematic review and meta-analysis by Saleh et al. examined randomized controlled trials of vagus nerve stimulation for chronic constipation.

Although study methods varied, the value of a meta-analysis is that it looks across multiple trials rather than relying on a single dataset. The overall conclusion supports continued investigation into vagus nerve stimulation as a potentially meaningful approach in bowel-function-related outcomes.

6. Inflammation and gut-related neuroimmune regulation

The vagus nerve is also increasingly studied for its role in the interface between the nervous and immune systems.

• Pediatric inflammatory bowel disease

Sahn et al. (2023) reported that transcutaneous auricular vagus nerve stimulation attenuated inflammatory bowel disease activity in children in a proof-of-concept clinical trial.

• Crohn’s disease and inflammatory activity

In a prospective open-label study, Haens et al. (2023) found that vagus nerve stimulation reduced inflammatory activity in Crohn’s disease patients.

These studies are exciting because they highlight the vagus nerve as a possible bridge between neural regulation and immune modulation. At the same time, it is important to interpret them cautiously and not generalize them beyond the specific populations studied.

What we can say—and what we cannot

It is important to be scientifically responsible here.

What current research suggests

The published literature suggests that taVNS may be relevant to:

• Gastric electrical rhythm

• Gastric motility

• Functional dyspepsia

• GI muscle activity

• Brain-gut communication

• Inflammatory signaling related to gut conditions

• Bowel function in constipation-related contexts

What current research does not yet establish?

At the same time, there is not yet a single definitive body of large-scale, standardized RCT evidence showing that taVNS directly treats all digestive or gastrointestinal disorders.

A more accurate summary is:

• There is promising and growing evidence
• The field is scientifically active and clinically interesting
• More large, direct, standardized trials are still needed

This distinction matters, especially when discussing wellness technologies in a medically complex area.

Beyond digestion: why taVNS matters for sleep, stress, pain, and inflammation?

For many people, digestive issues do not exist in isolation. They often overlap with:

• Stress
• Poor sleep
• Pain or physical discomfort
• Inflammatory burden
• Autonomic dysregulation

This is one reason taVNS has attracted broader interest across wellness and translational research.

Because the vagus nerve is tied to parasympathetic function, taVNS is often studied as a tool for supporting stress recovery and autonomic balance.

Sleep and autonomic regulation are deeply connected. Supporting a more regulated nervous system may also be relevant to restorative sleep and overnight recovery.

Neuromodulation approaches are increasingly explored in relation to pain processing, sensory regulation, and physical discomfort.

As the IBD and Crohn’s-related studies suggest, vagal pathways may also be relevant to neuroimmune regulation, a major area of ongoing interest in both clinical and translational science.

Why this matters to the G-PACT community?

The G-PACT community includes people navigating complex digestive and motility-related challenges, often alongside issues involving stress, sleep disruption, fatigue, and quality of life.

In that context, taVNS is compelling not because it is a cure-all—but because it represents a non-invasive, neuroscience-informed wellness approach that may be relevant to several interconnected domains:

• Stress resilience
• Autonomic balance
• Rest and recovery
• Sleep support
• Whole-body regulation
• Digestive wellness as part of the brain-gut axis

For people looking for supportive tools that may fit into a broader self-care or wellness routine, taVNS is a technology worth understanding.

ZenoWell’s perspective

At ZenoWell, we believe advanced neurotechnology should not remain confined to research settings alone. It should also become more accessible, practical, and human-centered in everyday wellness.

Our taVNS wellness technology is designed to support areas such as:

• Stress management
• Sleep support
• Recovery and regulation
• Comfort and resilience
• Whole-body wellness through nervous system support

For members of the G-PACT community—and for people who experience digestive discomfort alongside stress, poor sleep, or nervous system overload—this may offer a meaningful new lens: not only focusing on the gut itself, but on the broader systems that influence how the body restores, regulates, and responds.

Looking ahead

As sponsor and device donor for the 3rd annual G-PACT conference, ZenoWell is proud to support a community advancing awareness, education, and dialogue around digestive health and quality of life.

We are encouraged by the growing body of research connecting taVNS to digestive physiology, brain-gut signaling, autonomic balance, and inflammation-related pathways. While the science is still developing, the direction is clear: the vagus nerve is a vital regulator of whole-body function, and non-invasive approaches like taVNS are opening new possibilities for wellness-focused support.

We look forward to continuing this conversation with patients, researchers, clinicians, and advocates—and to helping bring neuroscience-based wellness tools to the people who may benefit from them most.

References

• Teckentrup, Vanessa, et al. "Non-invasive stimulation of vagal afferents reduces gastric frequency." Brain Stimulation 13.2 (2020): 470-473.
• Hong, Gun-Soo, et al. "Effect of transcutaneous vagus nerve stimulation on muscle activity in the gastrointestinal tract (transVaGa): a prospective clinical trial." International Journal of Colorectal Disease 34.3 (2019): 417-422.
• Steidel, Kenan, et al. "Transcutaneous auricular vagus nerve stimulation influences gastric motility: a randomized, double-blind trial in healthy individuals." Brain stimulation 14.5 (2021): 1126-1132.
• Zhu, Ying, et al. "Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia by enhancing vagal efferent activity." American Journal of Physiology-Gastrointestinal and Liver Physiology 320.5 (2021): G700-G711.
• Du, Peng, et al. "Transcutaneous auricular vagus nerve stimulation normalizes induced gastric myoelectrical dysrhythmias in controls assessed by body-surface gastric mapping." Neuromodulation: Technology at the Neural Interface 27.2 (2024): 333-342.
• Zhu, Ying, et al. "Noninvasive transcutaneous auricular vagal nerve stimulation improves gastric slow waves impaired by cold stress in healthy subjects." Neuromodulation: Technology at the Neural Interface 26.8 (2023): 1851-1857.
• Müller, Sophie J., et al. "Vagus nerve stimulation increases stomach-brain coupling via a vagal afferent pathway." Brain Stimulation 15.5 (2022): 1279-1289.
• Sahn, Benjamin, et al. "Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial." Bioelectronic Medicine 9.1 (2023): 23.
• D’Haens, Geert, et al. "Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn’s disease patients: a prospective open-label study." Journal of Crohn's and Colitis 17.12 (2023): 1897-1909.
• Saleh, Ahmad Omar, et al. "Vagal Nerve Stimulation for Chronic Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Neuromodulation: Technology at the Neural Interface (2026).